Early Use of RAAS Inhibitors May Benefit Children With Lupus Nephritis
Real-world data on use of RAAS inhibitors can be used to support future pragmatic studies to optimize management of childhood-onset SLE, according to investigators.
Real-world data on use of RAAS inhibitors can be used to support future pragmatic studies to optimize management of childhood-onset SLE, according to investigators.
Both renal and extra-renal manifestations of lupus nephritis need to be managed, according to investigators.
A second biopsy adds valuable information on lupus nephritis course, according to investigators.
Researchers investigated the patient factors that affect risk for mortality and lupus nephritis among patients with SLE.
The integrity of Bowman’s capsule may play a role in the progression of lupus nephritis, according to investigators.
Belimumab is a monoclonal antibody that inhibits B-lymphocyte stimulator.
Adverse effects of induction therapies for lupus nephritis may limit their use.
Proteinuria and estimated glomerular filtration rate cannot accurately distinguish between ongoing inflammatory injury and chronic kidney damage in lupus nephritis, investigators pointed out.
In a study, the calcineurin inhibitor tacrolimus proved to be noninferior to intravenous cyclophosphamide.
Researchers developed a consensus-based standardized corticosteroid dosing regimen for patients with childhood-onset systemic lupus erythematosus with lupus nephritis.